title: RISK OF RED BLOOD CELL ALLOIMMUNISATION IN RWANDA: ASSESSMENT OF PRETRANSFUSION CROSSMATCH TECHNIQUES USED IN DISTRICT HOSPITALS.
abstract: BACKGROUND
  Screening of alloantibodies in patients is not yet done in district hospitals of Rwanda. The practice is to transfuse ABO/D compatible blood following an immediate spin crossmatch (IS-XM) or indirect antiglobulin test crossmatch (IAT-XM).
  
  
  OBJECTIVE
  To assess the risk of red blood cell (RBC) alloimmunisation associated with the use of IS-XM compared to the IAT-XM in patients receiving blood transfusions in district hospitals in Rwanda.
  
  
  METHODS
  A cross-sectional comparative descriptive study.
  
  
  METHODS
  Four Rwandan district hospitals. Kirehe and Nyanza hospitals used IS-XM while Muhima and Ruhengeri hospitals used IAT-XM.
  
  
  METHODS
  Blood samples were obtained from 187 patients (101 with IS-XM and 86 with IAT-XM) transfused in January, February, October, and November of 2012.
  
  
  RESULTS
  The median age of blood recipients was 31 years (7 - 80) and 36% of them were male. Sixteen specific antibodies were identified in 12 patients: anti-RH1/D (2),anti-RH2/C (2), anti-RH3/E (2), anti-RH4/c (1), anti-RH5/e (2),anti-LE1/Lea (2),anti-JK1/Jka (1), anti-JK2/Jkb (1), anti-KEL1/K (1), anti-MNS1/M (1), and autoantibody (1).The global prevalence of redblood cell (RBC) alloimmunisationwas 6.4% (12/187). Thatprevalence was significantly higher in the IS-XM group (10.4%) than in the IAT-XM group (2.3%) with an odds ratio of 4.8; [95% CI=1.2-19.8]; and a p-value of 0.031.
  
  
  CONCLUSIONS
  The prevalence of red blood cell (RBC) alloimmunisation in 187 patients receiving blood transfusions was 6.4% and was higher in recipients from hospitals using IS-XM, with Rhesus (RH) system antibodies widely predominant (56.2%).We recommend that IAT-XM be used in all district hospitals in Rwanda to minimise this risk.
authors: CHU Liège, Sart-Tilman, Belgium.
authors: E
authors: E
authors: Ndahimana
authors: A
authors: A
authors: Gothot
authors: C
authors: C
authors: Gérard
authors: F
authors: F
authors: Senyana
authors: S
authors: S
authors: R'Zik
authors: O
authors: O
authors: Mukabayire
authors: L
authors: L
authors: Mutesa
mesh_terms: D000328:Adult; D001788:Blood Grouping and Crossmatching / Q000379:methods; D001803:Blood Transfusion / Q000379:methods; D003430:Cross-Sectional Studies; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D006767:Hospitals, District / Q000706:statistics & numerical data; D006801:Humans; D007159:Immunologic Tests / Q000379:methods; D007518:Isoantibodies / Q000097:blood*; D008297:Male; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D012432:Rwanda / Q000453:epidemiology; D065227:Transfusion Reaction
chemical_list: D007518:Isoantibodies